UTMD — Utah Medical Products Balance Sheet
0.000.00%
Last trade - 00:00
- $246.13m
- $153.27m
- $50.22m
- 93
- 57
- 29
- 61
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 42.8 | 51.6 | 61 | 75.1 | 92.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.74 | 4.1 | 5.13 | 5.54 | 3.39 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 54.9 | 62.3 | 73.2 | 89.9 | 106 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 10.7 | 11.3 | 11.1 | 10.2 | 10.6 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Total Assets | 110 | 112 | 116 | 124 | 135 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.45 | 3.79 | 3.75 | 5.96 | 4.71 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 8.69 | 8.92 | 8.5 | 9.62 | 7.14 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 101 | 103 | 107 | 114 | 128 |
Total Liabilities & Shareholders' Equity | 110 | 112 | 116 | 124 | 135 |
Total Common Shares Outstanding |